Influence
June 22, 2021

Regenstrief experts share cancer-related research as part of IU Simon Cancer Center Series

Two Regenstrief research scientists who focus on cancer research are sharing their knowledge in the Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s monthly series called “Simon Says.” 

The monthly virtual series was created to better connect cancer experts with the community, giving people the opportunity to hear about the latest research and ask questions.  

Dr. Clint Cary

Regenstrief Research Scientist K. Clinton Cary, M.D., MPH, is speaking at the June 30, 2021 presentation called “Keeping Our Eyes on the Ball: IU’s Leadership in Testis Cancer Research and Care.” He will be joined by a cancer survivor to discuss treatment options for testicular cancer, with a focus on nerve-sparing surgical techniques that were developed at IU. Dr. Cary is a urological oncologist who also conducts research on improving the health of patients with urologic cancers through health services and outcomes research in testis, bladder and prostate cancer. 

Shelley Johns, PsyD

On July 27, 2021, Regenstrief Research Scientist Shelley Johns, PsyD, will present “Waiting for the Other Shoe to Drop: Coping Effectively with Fear of Cancer Recurrence.” That fear is one of the most prevalent and disruptive problems that cancer survivors face. Dr. Johns works in the clinic with cancer survivors to help them cope with that fear, and she is conducting clinical trials to validate new ways to treat it. In this Simon Says session, she will discuss how her research seeks to support survivors in coping effectively with fear of recurrence.

Sign up for the upcoming sessions here.

Past Simon Says recordings are also available on the site.  

About K. Clinton Cary, M.D., MPH

In addition to his role as a research scientist at Regenstrief Institute, K. Clinton Cary, M.D., MPH, is an associate professor of urology and director of Urologic Oncology Research within the Department of Urology at Indiana University School of Medicine.

About Shelley Johns, PsyD  

In addition to her role as a research scientist at Regenstrief Institute, Shelley A. Johns, PsyD, is a board-certified clinical health psychologist for the Eskenazi Health Palliative Care Program. Dr. Johns also serves as an associate professor of medicine at Indiana University School of Medicine. 

Related News

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Researchers to study online therapy’s potential to prevent cognitive decline in ICU survivors

Indianapolis – Researchers from Indiana University Indianapolis, Regenstrief Institute and the IU School of Medicine’s Indiana Alzheimer’s Disease Research

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study

Joshua Vest, PhD, MPH

Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is